[
    [
        {
            "time": "",
            "original_text": "【A股舆情周评】长生生物疫苗造假营收大减 华联股份董事内讧股价反涨",
            "features": {
                "keywords": [
                    "长生生物",
                    "疫苗造假",
                    "营收大减",
                    "华联股份",
                    "董事内讧",
                    "股价反涨"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "零售"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【A股舆情周评】长生生物疫苗造假营收大减 华联股份董事内讧股价反涨",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]